Japanese Committee Recommends Approval For Novo Nordisk's Victoza And Novartis' Galvus
This article was originally published in PharmAsia News
Executive Summary
The First Committee on New Drugs at Japan's Ministry of Health, Labor and Welfare approved Nov. 27 Victoza (liraglutide) injection and Galvus (vildagliptin) for type 2 diabetes